Member Exclusive Interview

Targeted protein degradation: an interview with Ian Collins

In this interview with Ian Collins (The Institute of Cancer Research; London UK) learn more about PROTACs – Proteolysis Targeting Chimeras – a potential alternative to small molecule inhibitors. What are they? How do they work? What impact could they have on drug discovery?

Apr 01, 2019
3
0

Please sign in or register for FREE

No comments yet.